Literature DB >> 12368335

Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis.

Javier Martín1, Elena Samoilovich, Glynis Dunn, Angie Lackenby, Esphir Feldman, Alan Heath, Ekaterina Svirchevskaya, Gill Cooper, Marina Yermalovich, Philip D Minor.   

Abstract

The isolation of a capsid intertypic poliovirus recombinant from a child with vaccine-associated paralytic poliomyelitis is described. Virus 31043 had a Sabin-derived type 3-type 2-type 1 recombinant genome with a 5'-end crossover point within the capsid coding region. The result was a poliovirus chimera containing the entire coding sequence for antigenic site 3a derived from the Sabin type 2 strain. The recombinant virus showed altered antigenic properties but did not acquire type 2 antigenic characteristics. The significance of the presence in nature of such poliovirus chimeras and the consequences for the current efforts to detect potentially dangerous vaccine-derived poliovirus strains are discussed in the context of the global polio eradication initiative.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368335      PMCID: PMC136614          DOI: 10.1128/jvi.76.21.10921-10928.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

Review 1.  Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative.

Authors:  P E Fine; I A Carneiro
Journal:  Am J Epidemiol       Date:  1999-11-15       Impact factor: 4.897

2.  From the Centers for Disease Control and Prevention. Circulation of a type 2 vaccine-derived poliovirus--Egypt, 1982-1993.

Authors: 
Journal:  JAMA       Date:  2001-03-07       Impact factor: 56.272

3.  Interaction of the poliovirus receptor with poliovirus.

Authors:  Y He; V D Bowman; S Mueller; C M Bator; J Bella; X Peng; T S Baker; E Wimmer; R J Kuhn; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

4.  Acute flaccid paralysis associated with circulating vaccine-derived poliovirus--Philippines, 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-10-12       Impact factor: 17.586

5.  Comparative study of five methods for intratypic differentiation of polioviruses.

Authors:  H G van der Avoort; B P Hull; T Hovi; M A Pallansch; O M Kew; R Crainic; D J Wood; M N Mulders; A M van Loon
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

6.  Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees.

Authors:  N S Cuervo; S Guillot; N Romanenkova; M Combiescu; A Aubert-Combiescu; M Seghier; V Caro; R Crainic; F Delpeyroux
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Natural genetic exchanges between vaccine and wild poliovirus strains in humans.

Authors:  S Guillot; V Caro; N Cuervo; E Korotkova; M Combiescu; A Persu; A Aubert-Combiescu; F Delpeyroux; R Crainic
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  The vaccine origin of the 1968 epidemic of type 3 poliomyelitis in Poland.

Authors:  J Martín; G L Ferguson; D J Wood; P D Minor
Journal:  Virology       Date:  2000-12-05       Impact factor: 3.616

9.  Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China.

Authors:  H M Liu; D P Zheng; L B Zhang; M S Oberste; M A Pallansch; O M Kew
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

10.  Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus.

Authors:  Olen Kew; Victoria Morris-Glasgow; Mauricio Landaverde; Cara Burns; Jing Shaw; Zacarías Garib; Jean André; Elizabeth Blackman; C Jason Freeman; Jaume Jorba; Roland Sutter; Gina Tambini; Linda Venczel; Cristina Pedreira; Fernando Laender; Hiroyuki Shimizu; Tetsuo Yoneyama; Tatsuo Miyamura; Harrie van Der Avoort; M Steven Oberste; David Kilpatrick; Stephen Cochi; Mark Pallansch; Ciro de Quadros
Journal:  Science       Date:  2002-03-14       Impact factor: 47.728

View more
  28 in total

1.  Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains.

Authors:  V Pliaka; Z Kyriakopoulou; D Tsakogiannis; I G A Ruether; C Gartzonika; S Levidiotou-Stefanou; A Krikelis; P Markoulatos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-05       Impact factor: 3.267

2.  Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001.

Authors:  Hiroyuki Shimizu; Bruce Thorley; Fem Julia Paladin; Kerri Anne Brussen; Vicki Stambos; Lilly Yuen; Andi Utama; Yoshio Tano; Minetaro Arita; Hiromu Yoshida; Tetsuo Yoneyama; Agnes Benegas; Sigrun Roesel; Mark Pallansch; Olen Kew; Tatsuo Miyamura
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine.

Authors:  E A Cherkasova; M L Yakovenko; G V Rezapkin; E A Korotkova; O E Ivanova; T P Eremeeva; L I Krasnoproshina; N I Romanenkova; N R Rozaeva; L Sirota; V I Agol; K M Chumakov
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Molecular characterization of wild-type polioviruses isolated in Greece during the 1996 outbreak in Albania.

Authors:  Zaharoula Kyriakopoulou; Christine Kottaridi; Evaggelos Dedepsidis; Eugenia Bolanaki; Stamatina Levidiotou-Stefanou; Panayotis Markoulatos
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

5.  Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range.

Authors:  Jaume Jorba; Ray Campagnoli; Lina De; Olen Kew
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

6.  Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba Province, Argentina.

Authors:  Judith E Mueller; Maël Bessaud; Q Sue Huang; Laura C Martinez; Patricia A Barril; Viviane Morel; Jean Balanant; Judy Bocacao; Joanne Hewitt; Brad D Gessner; Francis Delpeyroux; Silvia V Nates
Journal:  Appl Environ Microbiol       Date:  2009-01-05       Impact factor: 4.792

7.  Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China.

Authors:  Hong-Mei Liu; Du-Ping Zheng; Li-Bi Zhang; M Steven Oberste; Olen M Kew; Mark A Pallansch
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia.

Authors:  Soile Blomqvist; Carita Savolainen; Pia Laine; Päivi Hirttiö; Elisa Lamminsalo; Eija Penttilä; Silver Jöks; Merja Roivainen; Tapani Hovi
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Development of a multiplex RT-PCR assay for the identification of recombination types at different genomic regions of vaccine-derived polioviruses.

Authors:  T G Dimitriou; Z Kyriakopoulou; D Tsakogiannis; A Fikatas; C Gartzonika; S Levidiotou-Stefanou; P Markoulatos
Journal:  Virus Genes       Date:  2016-04-20       Impact factor: 2.332

10.  Changes in population dynamics during long-term evolution of sabin type 1 poliovirus in an immunodeficient patient.

Authors:  John K Odoom; Zaira Yunus; Glynis Dunn; Philip D Minor; Javier Martín
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.